In the sixth in a series of debates about the world’s HIV response hosted by the World Bank and USAID, physician-scientists debated how best to transform the exciting results from the HPTN) 052 study, which demonstrated that those with HIV infection who received immediate treatment with antiretroviral therapy (ART) were 96 percent less likely to transmit HIV to their uninfected sexual partners than those whose treatment was delayed. The panelists were tasked with debating not only how to apply treatment as prevention (TasP) quickly, and how to add it to the combination prevention tool kit effectively, but more so whether or not it makes sense to have countries spend a majority of what is likely to be a flat or declining HIV prevention budget on TasP.
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Lockdowns due to COVID-19 projected to stall TB detection and treatment leading to increased incidence, deaths globally over next five years
While stay-in-place and physical distancing measures to control the spread of COVID-19 are projected to also slow the spread of other illnesses, lockdowns prompted by that […]
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
The following is a guest post by Bridgit Adamou, MPH, MEASURE Evaluation Young people suffer disproportionately from negative reproductive health outcomes, including acquiring HIV and other […]